BACKGROUND: Arrhythogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterized by right ventricular remodeling and ventricular arrhythmia. To date, 16 ARVC causative genes have been identified from human genetic studies, accounting for about 60% of ARVC probands. Genetic basis for the remaining 40% ARVC probands remain elusive.
INTRODUCTION 1
Arrhythmogenic right ventricular cardiomyopathy (ARVC), also referred to as arrhythmogenic 2 right ventricular dysplasia (ARVD), is a rare inherited cardiac muscle disorder that can lead to 3 heart failure and sudden cardiac death (SCD) 1 . The prevalence of ARVC in the general 4 population is between 1:1,000 and 1:5,000, accounting for up to 50% SCD in the United 5
States 2-4 . ARVC is characterized by structural abnormalities in the right ventricle (RV) and 6 ventricular arrhythmia at early stages. Left ventricular (LV) involvement becomes common with 7 disease progression, and the biventricular involvement prompted recent recommendation of 8 using a broader term, arrhythmogenic ventricular cardiomyopathy (ACM), for this disease 5, 6 . 9
Current management of ARVC is mostly palliative and focuses on delaying disease progression 10 and preventing SCD. No curative treatment is available for this life-threatening disease 1 . 11
Human genetic studies of ARVC probands have linked 16 genes to ARVC to date 1, 7 , among 12 which seven encode desmosomal proteins located in the intercalated disc (ICD). Mutations in 13 desmosomal protein coding genes, such as PKP2, DSP and DSG2, account for up to 63% of 14 the ARVC probands 1, 8 . A small percentage of ARVC probands have sequence variants in non-15 desmosomal protein-encoding genes such as CTNNA3 and CDH2 9, 10 . Mouse models for five 16 desmosome/ICD protein coding genes (DSP, DSG2, DSC2, PKP2, JUP) have been generated 17 through either targeted genetic deletion or transgenic overexpression of genes with disease-18 causing mutations 8, 11 . The key features of human ARVC phenotypes such as structural 19 abnormalities in the ventricles, spontaneous ventricular tachicardia (VT), and SCD, can be 20 recapitulated in the majority of these mouse models. Certain aspects of human ARVC, such as 21 fibrofatty infiltration, however, was only noted in the mouse model involving DSP 12, 13 , but not 22 those involving DSG2, DSC2 and JUP 8, 14 . Because of the convenience of embryonic 23 morpholino knock-down and amenability to high-throughput genetic and compound screening, 24 zebrafish ARVC models for DSC2 and JUP have also been developed 15, 16 . 25
Through an insertional mutagenesis screen in zebrafish, we recently identified the gene-1 breaking transposon (GBT) 002 as a mutant that exerted deleterious modifying effects on 2 doxorubicin-induced cardiomyopathy (DIC) 17 . GBT002 was later determined as a loss-of-3 function mutant that disrupts sorbs2b (sorbin and SH3 domain containing 2b), one of the two 4 SORBS2 orthologues in zebrafish 17 . SORBS2, also known as Arg/c-ab1 kinase binding protein 5 2 (ArgBP2), encodes a member of the SOHO adaptor family protein that contains a Sorbin 6 domain at its N terminus and three SH3 domain at its C terminus 18 . The encoded protein 7 manifests a restricted subcellular expression pattern, including association with stress fibers 19 , 8 and sarcomeric Z discs in cardiomyocytes 20, 21 . Besides our evidence from zebrafish, several 9 recent studies also suggested the cardiac involvement of Sorbs2. First, knock-down of Sorbs2 10 in neonatal rat cardiomyocytes in culture resulted in cellular hypertrophy 22 . Second, SORBS2 11 was a candidate gene in regions of copy number variations linked to congenital heart disease in 12 human 23 . Third, expression of SORBS2 protein was found to be significantly increased in the 13 sera of patients with acute myocardial infarction, but depleted in the infarcted myocardia 24 . 14 However, in vivo cardiac phenotypes have not been reported in a Sorbs2 knock-out (KO) mouse 15 model 25 . 16
Here, we reported detailed cardiac studies of Sorbs2 in mouse. We revealed that Sorbs2 17 encodes an ICD protein, and Sorbs2 KO mice exhibit ARVC-like phenotypes including right 18 ventricular cardiomyopathy, VT, and premature death. Scanning a cohort of 59 Chinese Han 19 patients with ARVC led to the identification of five rare sequence variants. Collectively, our 20 results support that the Sorbs2 KO mouse is an ARVC model and SORBS2 as a previously 21 unrecognized susceptibility gene to ARVC. 22
METHODS 1
An expanded Materials and Methods is provided in the online-only Data Supplement. All the 2 supporting data and materials within the article will be made available upon reasonable request. 3
Statistical Analysis 4
Kaplan-Meier survival curve, echocardiography (ECG) and magnetic resonance imaging 5 (MRI) analyses are from cumulative data. The unpaired two-tailed Student's t-test was used to 6 compare 2 groups. One-or two-way analysis of variance (ANOVA) was used to assess 7 differences among multiple groups, as appropriate. Tukey test was applied for the post hoc 8 analysis to confirm the diiference. The log-rank test was used to determine the difference in 9 animal survival. Chi-square test was used to determine the enrichment of pathogenic variants in 10 SORBS2 gene from ARVC patients. All quantitative data are presented as mean ± standard 11 deviation (SD). P values less than 0.05 were considered to be significant. All statistical analyses 12
were performed with GraphPad Prism 7 software. 13
14

RESULTS
15
Sorbs2 is an intercalated disc protein in cardiomyocytes 16
In mouse, there is a single Sorbs2 gene in chromosome 8 (NM_001205219), encoding a protein 17 that is highly conserved with human SORBS2, especially in its N-terminal sorbin homologue 18 domain and C-terminal SH3 domain where they share more than 95% homology ( Figure 1 in the 19 online-only Data Supplement). Expression of Sorbs2 protein is highly enriched in the mouse 20 heart ( Figure 1A ). The mouse cardiac Sorbs2 is around 120 kilo Dalton (kDa) in size, whereas 21 its brain isoform is about 150 kDa ( Figure 2 in the online-only Data Supplement) 25 , suggesting 22 there exists tissue-specific alternative splicing events and/or post-translational modification. At 23 the subcellular level, Sorbs2 is localized strongly in the intercalated discs (ICD) of 1 cardiomyocytes, with weaker localization in the perinuclear areas and the Z discs ( Figure 1B) . 2
To resolve the Sorbs2 expression within ICD, we conducted double immunostaining using a 3 Sorbs2 antibody and antibodies against β-catenin, plakoglobin (Pkg), or connexin 43 (Cx43), 4 markers of the adhesion junction, desmosome, or gap junction structures, respectively. We 5 found that Sorbs2 mostly co-colocalizes with β-catenin, partially with Pkg, while only slightly with 6
Cx43 ( Figure 1C ). The weighted co-localization efficiency of Sorbs2 is about 60% with β-7 catenin, 20% with Pkg, and 6% with Cx43, suggesting that Sorbs2 is mainly localized in the 8 adhesion junction, and partially in the desmosome. 9
Deleterious modifying effects of GBT002/Sorbs2 on DIC is cardiomyocyte-primary and 10 conserved in mouse 11
To elucidate cardiac functions of Sorbs2, we first studied the doxorubicin-induced 12 cardiomyopathy (DIC) modifying effects in the zebrafish gene-breaking transposon (GBT)002 13 mutant. Because the two Loxp sites in the GBT vector enables cardiomyocyte-specific genetic 14 manipulation 26 , we crossed Tg(cmlc2:cre-ER), a myocardium-specific expressed and 15 hydroxytamoxifen inducible Cre transgenic fish line 27 , into the GBT002/sorbs2b muant for a 16 cardiomyocyte-specific rescue experiment. We found that the mutagenic insertion was 17 effectively removed and sorbs2b transcript was fully restored in the myocardium of the GBT002 -18 /-;Tg(cmlc2:cre-ER) double mutant/transgenic fish upon hydroxytamoxifen treatment (Figure 3 in 19 the online-only Data Supplement). While GBT002 -/homozygous mutant manifests no visually 20 noticeable phenotypes, after doxorubicin (DOX) stress, the GBT002 -/mutant exhibited 21 significantly deleterious DIC modifying effect, as indicated by the increased fish mortality ( Figure  22 2D in the online-only Data Supplement). This deleterious DIC modifying effect of 23 GBT002/sorbs2b was largely rescued in the GBT002 -/-;Tg(cmlc2:cre-ER) double 24 mutant/transgenic fish, suggesting a critical contribution of myocardial expression of sorbs2b to 1 its DIC modifying effects. 2
To prove the conservation of the DIC modifying effects in mammals, we obtained the Sorbs2 e8 3 knock-out (KO) mice (B6N(Cg)-Sorbs2 /J), in which a targeted deletion of 1903 bp nucleotides 4 removes part of intron 7, the whole exon 8, and part of intron 8 from the Sorbs2 genomic locus 5 (Figure 2A Figure 2C ). At the 9 protein level, the Sorbs2 protein is about 50% reduced in the Sorbs2 e8/+ heterozygous and 10 nearly completely absent in the Sorbs2 e8/e8 homozygous mice in all 4 cardiac chambers, as 11 indicated by Western blots using an antibody that recognizes a C-terminal antigenic epitope of 12 the Sorbs2 protein ( Figure 2D , and Figure 1 in the online-only Data Supplement). In the 13 Sorbs2 e8/e8 mice, Sorbs2 protein in the muscle and its larger isoform in the brain are also mostly 14 ablated ( Figure 2A in the online-only Data Supplement). 15
Consistent with the zebrafish data, we noted deleterious modifying effects of Sorbs2 e8/+ 16 heterozygous mice on DIC. Mild but significant reduction of right ventriclular (RV) function was 17 noted upon DOX stress due to enlarged end-systolic diameter ( Figure 3A ). Other cardiac pump 18 indice remained unchanged ( Table 1 in the online-only Data Supplement). We did not conduct 19 detailed studies of the DIC modifying effects of Sorbs2 e8/e8 homozygous mice, because of the 20 interference of severe cardiac phenotypes, as will be decribed below. 21
Depletion of Sorbs2 leads to RV dilation, cardiac dysfunction, premature death, and 22 ventricular arrhythmia in mice 23
Sorbs2 e8/e8 homozygous mice are fertile, but started to die at about 3.5 months old, and in rare 1 cases they could survive to 7 months ( Figure 3B ). Using the non-invasive cardiac magnetic 2 resonance imaging (MRI), we detected prominent RV dilation in the Sorbs2 e8/e8 mice as early as 3 2 months and it got worse at 4 months ( Figure 3C ). The RV bulges out along the short axis, and 4 the overall shape of the ventricle changes from crescent to triangle-like in lateral view ( Figure  5 3D). The ventricular septum in the Sorbs2 e8/e8 mice becomes progressively bended, ranging 6 from mild at 2 months to severe at 4 months, in contrast to the straight ventricular septum in wild 7 type (WT). Both heart weight and left ventricular posterior wall thickness at end diastole 8 (LVPWd) are increased significantly, suggesting the presence of LV hypertrophy (Table 1) . 9
Cardiac function in both RV and LV drop significantly. In association with RV dilation at 4 10 months, fibrosis was detected in both RV and LV, and more prominently in the septum ( Figure  11 3E). Occasionally, adipose tissue deposition was noted in the LV, but not in other chambers. 12
Transcription levels of molecular markers for heart failure such as Nppa, Nppb and β-Mhc are 13 markedly elevated in both LV and RV ( Figure 3F) . 14 Besides the profound cardiac structural remodeling, abnormal electrical remodeling was also 15 striking in the Sorbs2 e8/e8 mice. Significant increase in QRS and S wave durations with the 16 development of right bundle branch block (RBBB) are commonly detected in the Sorbs2 e8/e8 17 mice at 4 months of age ( Figure 4A ). Random 2-minute electrocardiogram (ECG) recordings in 18 anesthetized animals showed spontaneous arrhythmias including premature ventricular 19 contractions (PVCs), nonsustained ventricular tachycardias (VTs), and polymorphic VTs in the 20 Sorbs2 e8/e8 mice (7/31), but not in WT controls (0/37 ) ( Figure 4B ) (χ 2 , p<0.05, Chi-square test). 21
Electrophysiological studies in Langendorff-perfused hearts showed that the ventricular effective 22 refractory period (VERP) is markedly prolonged in Sorbs2 e8/e8 mice compared to WT ( Figure  23 4C). Sustained VTs with durations greater than 30 seconds were induced by programmed 24 electrical stimulation or burst pacing in 9 out of 10 Sorbs2 e8/e8 hearts (90%), but only in 3 out of 25 12 WT hearts (25%) (χ 2 , p<0.05, Chi-square test). These results suggest that the Sorbs2 e8/e8 1 mice have a greater propensity to develop spontaneous and induced ventricular 2 tachyarrhythmias which might be pertinent to the shortened life-span of these animals. 3
Intracellular recordings of action potentials from the endocardial side of RV showed marked 4 electrophysiological abnormalities in Sorbs2 e8/e8 mice ( Figure 4D ). The resting potentials are 5 significantly depolarized in Sorbs2 e8/e8 mice compared to WT. Action potential amplitudes and 6 upstroke velocities (dV/dt) are significantly reduced in Sorbs2 e8/e8 mice ( Figure 4E ). There are 7 remarkable prologation of action potential durations at 50 % and 90% repolarization (APD50 8 and APD90), as well as shortening in the effective refractory period (ERP) detected in the 9 Sorbs2 e8/e8 mice. 10
Sorbs2 e8/e8 manifests disrupted ICD structure and reduced expression of Cx43 protein 11
Prompted by the subcellular expression of Sorbs2 in ICD, we sought to examine whether 12
Sorbs2 depletion affects the expression of other ICD proteins. Through immunostaining of 13 sectioned hearts, we firstly confirmed depletion of the Sorbs2 expression in both ICD and Z disc 14 in the Sorbs2 e8/e8 hearts at 4 months of age ( Figure 4 in the online-only Data Supplement). Loss 15 of Sorbs2 does not seem to affect the protein expression levels of adhesion junction or 16 desmosomal proteins such as β-catenin and Pkg ( Figure 4 in the online-only Data Supplement); 17 however, the expression level of the gap function protein Cx4 is markedly reduced. While the 18 expression level of N-cadherin remains largely unchanged, its dotted expression pattern mostly 19 seen in WT heart was changed to a continuous line in Sorbs2 e8/e8 mutant hearts ( Figure 5A ), 20 and from an alternating pattern with Pkg to a largely overlapping pattern ( Figure 5 in the online-21
only Data Supplement). The significant reduction of Cx43, but not other ICD proteins, was 22 confirmed using Western blot analysis ( Figure 5B ). Downregulation of Cx43 is known to impair 23 electrical impulse conduction and create substrates for cardiac arrhythmias 28, 29 . A recent study 24
reported Sorbs2 as a potent RNA binding protein to stabilize tumor-suppressor gene expression 25 in ovarian cancer 30 . We thus carried out targeted RNA immuoprepicipitation (RIP) assay and 1 found that Sorbs2 protein could bind the Cx43 mRNA ( Figure 5C ). Together with the data that 2
Cx43 transcript was significantly decreased in the Sorbs2 e8/e8 mice hearts as well ( Figure 5D ), 3
we speculated that disrupted transcriptional regulation of Cx43 by Sorbs2 might contribute to 4 the cardiac arrhythmia in the Sorbs2 e8/e8 mice. More detailed mechanistic study along this 5 direction may warrant further investigation. 6
At the ultrastructural level, ICD in a WT mouse heart is a unique structure at the longitudinal 7 junction between two neighboring cardiomyocytes consists of two regions: the tread region that 8 is typically in parallel with Z discs along the myofibrils, and the step region that connects the 9 tread regions and is typically perpendicular to the tread and Z discs ( Figure 5E ). This highly 10 organized ICD structure connects the myofibrils from two neighboring cardiomyocytes across 11 the membrane, ensuring coordinated contraction 31 . In the Sorbs2 e8/e8 mice hearts at 4 months 12 old, however, there is no clear separation between the tread region and the step region ( Figure  13 5E). The ICDs are no longer in parallel with the Z discs, but are slanted and intersect with Z 14 discs. The ICDs also appear less flat and the amplitude of folding is significantly increased. As a 15 consequence, loss of sarcomere structures in the connecting region between myofibrils and 16 intercalated discs are frequently detected ( Figure 5E ). 17
Identification and functional validation of pathogenic variants in the SORBS2 gene found 18 in human ARVC patients 19
Given the cardiac-enriched expression of Sorbs2 protein, its subcellular expression pattern in 20 the ICDs, and depletion of which in the Sorbs2 e8/e8 mice leads to ARVC-like phenotypes in 21 human including the prominent RV dilation, cardiac arrhythmia and premature death, we 22 postulated that SORBS2 is a previously unrecognized gene for ARVC. To test this hypothesis, 23
we performed targeted sequencing as well as Sanger sequencing in a 59 unrelated Han 24
Chinese ARVC patient cohort and WES in 402 health controls, aiming to identify potential 1 pathogenic variants in the coding region of the SORBS2 gene. Patients with ARVC are 2 significantly younger and have larger right ventricular interior diameter (RVID), right atrial interior 3 diameter (RAID) than health controls ( Table 2 in the online-only Data Supplement). Five rare 4 variants were identified in the SORBS2 gene from five unrelated ARVC patients diagnosed with 5 the task force criteria for ARVC ( Figure 6B , Table 2 , and Figure 6 , Table 3 , Table 4 these three variants were reported in human gene mutation database (HGMD) or ClinVar 10 databases. Chi-square test showed potential pathogenic variants in the SORBS2 gene were 11 significantly enriched in ARVC patients (p=0.0444). Both pathogenic variants are splicing 12 variants predicted to affect splicing donors and/or acceptors, potentially leading to functional 13 disruption of the SORBS2 protein in the patients with these mutations. Among these two ARVC 14 patients, one patient also harbors a nonsense variant in PKP2 gene (c.2421C>A, p.Tyr807Ter), 15 a known ARVC causative gene (Table 3 in T wave inversion in the right precordial leads (V 1 , V 2 and V 3 ); RV dilation and fatty filtration were 20 confirmed by MRI ( Figure 6B, 6C) . 21
To validate the pathogenicity of the c.679+1G>T splicing variant, we first conducted mini gene 22 hybridization assay and confirmed that the c.679+1G>T mutation is able to induce exon 23 skipping events ( Figure 6D ). Loss of exon 11 putatively disrupts the Sorbin homologue domain 24 and results in SORBS2 protein loss-of-function. To further assess the pathogenicity of the 25 c.679+1 G>T point mutation at the organ level, we mimic the genetic lesion in a zebrafish 1 embryo by using the morpholino technology. The targeted sites are exon 6 in sorbs2a 2 (ENSDART00000138475.2) and exon 10 in sorbs2b (ENSDART00000142605.3), two 3 corresponding exons to exon 11 in human SORBS2, as evidenced by remarkable sequence 4 conservation in the surrounding exons ( Figure 7 in the online-only Data Supplement). Injection 5 of sorbs2a morpholino caused skipping of exon 6 in sorbs2a RNA transcript, while injection of 6 sorbs2b morpholino caused intron retention, resulting in a premature stop codon that 7 presumably leads to truncation of the Sorbs2b protein ( Figure 6D, 6E) . While injection of 8 sorbs2a and sorbs2b morpholino alone did not cause obvious abnormalities, co-injection of both 9 sorbs2a and sorbs2b morpholino led to significantly decreased fraction shortening (FS) and 10 increased heart rate ( Figure 6F ), confirming the pathogenicity of this splicing variant. 11 DISCUSSION 12
SORBS2 is a new susceptibility gene for ARVC 13
Prompted by our genetic studies in zebrafish, we studied cardiac expression and function of 14 Sorbs2 in mouse. We noted its cardiac enriched expression pattern and the desmosomal/ICD 15 subcellular localization within cardiomyocytes. Homozygous Sorbs2 e8/e8 mice manifest 16 characteristic features of other mouse ARVC models, such as those based on Dsg2, Jup and 17
Dsp genes 12, [33] [34] [35] , including right ventricle (RV) remodeling and dysfunction 12, 35, 36 , 18 spontaneous sustained and non-sustained ventricular tachycardia 32 , and premature sudden 19 death at about 3.5 months of age. Importantly, two pathogenic mutations (splicing variants) out 20 of five rare variants in the SORBS2 gene were identified from a cohort of 59 Han Chinese 21 patients, while only one likely pathogenic variant (missense) was identified in 402 healthy 22 controls. Functional validation studies in the zebrafish model confirmed the pathogenicity of one 23 splicing variant. These data suggest that pathogenic mutations, most likely loss-of-function 24 variants in SORBS2 gene, are associated with ARVC. Together, these studies in both animal 25 models and human genetics strongly suggested SORBS2 as an ARVC susceptibility gene, 1 pathogenic mutations in which account for about 3.4% (2 out of 59) of the ARVC patients. 2
Scanning SORBS2 mutations in larger patient cohorts are needed to accurately determine its 3 prevalence. 4
Different from other AVRC genes that were mostly discovered through human genetic studies, 5
SORBS2 is the first ARVC gene that was initially identified from expression and phenotypic 6 studies in animal models. We acknowledged limitations associated with our study. Fatty 7 infiltration, a pathogenic hallmark for human ARVC, was not prominent in our Sorbs2 e8/e8 mouse 8 model. Similarly, it does not present in most of the mouse ARVC models for other well-9
established ARVC genes such as JUP, DSG2 and PKP, neither 12, 33 . The only mouse ARVC 10 model with fibro-fatty infiltration phenotype is the Dsp-deficient mouse 12, 13 . Species difference 11 has been postulated to explain the discrepency, becuase a mouse heart does not show 12 evidence of epicardial fat as typically seen in a human heart. Moreover, the present human 13 genetic studies were conducted in sporadic ARVC patients. Pedigree studies are needed to 14 further validate SORBS2 as an ARVC causative gene. 15 16
Sorbs2 e8/e8 is a mouse model for SORBS2 ARVC 17
The Sorbs2 e8/e8 mouse provides a useful animal model to decipher the mechanisms of SORBS2 18 ARVC. In ARVC patients, sudden cardiac death (SCD) and ventricular arrhythmia are often 19 seen at the early phase when there is no obvious heart structural remodeling 37 . Similar 20 progressive pathogenesis was observed in the Sorbs2 e8/e8 mice. Spontaneous and induced 21 ventricular arrhythmias are noted as early as 2 months of age in the Sorbs2 e8/e8 mice (data not 22 shown). RV remodeling occurs later, followed by LV hypertrophy. Electrophysiology 23 experiments identified multiple levels of abnormalities. First, the ECG abnormalities with 24 prolonged and bifid P waves and RBBB consistent with atrial and ventricular conduction 1 abnormalities. Second, spontaneous atrial and ventricular arrhythmias were recorded in 2 anesthesized Sorbs2 e8/e8 mice. Third, microelectrode studies showed ventricular depolarized 3 resting potentials, reduced action potential upstroke dV/dts, reduced action potential amplitudes, 4 and prolonged ADP50s, ADP90s and VERPs, indicating potential derangements in a multitude 5 of ion channels including those that encode IK 1 , I Na , I to , and I K . Fourth, Sorbs2 deficient hearts 6 are susceptible to induction of VT, which may involve reentry and triggered activity in 7 mechanisms. These findings indicate that the loss of Sorbs2 leads to loss of structural integrity 8 and is accompanied by a wide range of electrophysiological abnormalities that promote 9 development of arrhythmias and premature death. 10
Compared to other well-established ARVC susceptibility genes that encode desmosome 11 proteins, SORBS2 encodes an ICD protein that is predominantly localized to the adhesion 12 junction but imparts its effects in gap junctional proteins. Nevereless, similar ICD structural 13 disruption was noted in the Sorbs2 e8/e8 mice, as often seen in ARVC mouse models and human 14 patients, including breakdown of the ICD structure, a widened desmosome gap, and mislocated 15 desmosome 35, 38 . We also noted the loss of myofibrils in the proximity of the ICD region, as has 16 been reported in Boxer dogs with ARVC 39 . Sorbs2 depletion did affect the expression pattern of 17 other ICD proteins, such as N-cadherin, also known as cadherin-2 (Cdh2), which is encoded by 18 a recently identified ARVC gene 9 . How Sorbs2 protein interacts with other ICD proteins, and 19 whether Sorbs2 deficiency regulates known ARVC pathways such as Wnt, YAP and/or 20 mechanical force transmission warrants future investigation 12, 40, 41 . Intriguingly, Sorbs2 21 deficiency is associated with dramatical downregulation of Cx43 expression in mouse. Given the 22 fact that marked reduction of Cx43 have been found in many ARVC patients 28 42, 43 , it would be 23 interesting to investigate the underlying mechanism its contribution to arrhythmic phenotypes in 24
ARVC. 25
In summary, our integrated studies from zebrafish, mouse and human genetics suggested 1 SORBS2 as a new susceptibility gene for ARVC, which can be modeled by a Sorbs2 KO 2
mouse. 3
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